FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to a drug with antiviral activity with respect to viruses of influenza types A and B. Application of dihydroquercetin and/or its calcium salts as a drug with antiviral activity with respect to viruses of influenza types A and B.
EFFECT: drug shows improves antiviral activity with respect to viruses of influenza types A and B.
4 cl, 6 dwg, 3 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS, BASED ON COPPER (III)-CONTAINING DIHYDROMELETIN COMPLEX COMPOUND, POSSESSING ANTIVIRAL ACTIVITY | 2013 |
|
RU2553627C2 |
| PHARMACEUTICAL SALTS OF AMINOBICYCLO[2,2,1]HEPTANE AS NF-KB TRANSCRIPTION FACTOR INHIBITORS WITH ANTIVIRAL ACTIVITY (VERSIONS) AND USING THEM | 2009 |
|
RU2448692C2 |
| DIINDOLYLMETHANE DRUG PREPARATION AND USING IT FOR TREATING INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2537025C1 |
| ANTI-INFLUENZA AGENT | 2004 |
|
RU2286770C2 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| PREPARATION BEING OF ANTIHYPOXIC AND CYTOPROTECTOR ACTIVITIES AND APPLIED FOR DECREASING REMANTADIN TOXICITY AT TREATING GRIPPE INFECTION | 2005 |
|
RU2302236C2 |
| ANTIVIRAL PREPARATION | 1994 |
|
RU2071323C1 |
| BIOLOGICALLY ACTIVE PEPTIDE COMPLEXES | 2011 |
|
RU2470031C2 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST INFLUENZA A AND SARS-CoV-2 VIRUSES | 2022 |
|
RU2796748C1 |
| RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
